This also comes after both the FDA and CDC earlier this summer approved nirsevimab, an RSV antibody injection, for infants ...

In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses ...

Generally, experts recommend COVID-19 and flu vaccines for most people and RSV vaccines for some. The vaccines are all safe ...

The news comes as coronavirus cases rise in California and across the country. Along with the new COVID vaccines, ...

Vaccination against respiratory syncytial virus for adults over 60 is likely to be cost-effective by preventing illness, ...

The Food and Drug Administration approved and granted emergency use authorization on Aug. 22, 2024, for the newest, updated ...

If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...

AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) is the first FDA-approved RSV vaccine to help prevent lung and lower airway infection from RSV in people 60 and older. The CDC recommends that ...

The only strain of the flu known to cause pandemics is spreading in Palm Beach County, along with a respiratory disease that ...

With the flu season imminent, new COVID-19 and influenza vaccines are available. What’s new with the vaccines and when should ...

GSK plc (LSE/NYSE: GSK) today announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, reactogenicity and safety of AREXVY (Respiratory ...

Respiratory syncytial virus, or RSV, is an upper respiratory infection that can cause serious complications, particularly for older adults and infants. But for the first time, there's a vaccine that ...